Insight Molecular Diagnostics Inc

IMDXNASDAQ · In Vitro & in Vivo Diagnostic Substances

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

32.6M

on 2026-06-30, from 8.27M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

S-3 of 2024-10-16. Not read yet. S-3 ↗

8 of its filings are not read yet.

Warrants

573K

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

2.6 quarters

$17.8M on 2026-06-30 ÷ $6.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-02-10	Registered direct offering incl. 1.04M pre-funded	4,525,976	$5.75	$26.0M	424B5 ↗
2026-02-10	Registered direct offering incl. 1.04M pre-funded	4,525,976	not read	not read	8-K ↗
2025-02-07	Registered direct offering	3,609,755	$2.05	not read	424B5 ↗
2025-02-07	Private placement incl. 3.07M pre-funded	10,606,633	not read	$21.7M	8-K ↗